BIO-Europe^® 2013 Press Releases

November 14, 2012BIO-Europe^® 2012 hosted over 3,000 life science leaders in Hamburg, Germany November 12–14 The 18^th annual BIO-Europe^® international partnering conference was held in Hamburg, Germany November 12–14, 2012 at the CCH Congress Center Hamburg. Over 3,000 attendees from 48 countries had access to 3,000 projects available for partnering over three days. Delegates also scheduled upwards of 15,000 one-to-one partnering meetings utilizing partneringONE^{®...more ►}

October 22, 2012BIO-Europe^® 2012 presenting companies offer preview of market innovation to VC and pharma investors The 18^th annual BIO-Europe^® international partnering conference will be held in Hamburg, Germany November 12–14, 2012 at the CCH Congress Center Hamburg. Europe's largest partnering conference attracts the world's top dealmakers from biotech, pharma and finance along with exciting emerging companies. The event, organized by EBD Group, the leading partnering fir...more ►

October 8, 2012Partnering opportunities kicked off last week for BIO-Europe^® 2012 in November Partnering opened last week for BIO-Europe^® international partnering conference in Hamburg, Germany November 12–14, 2012. The 18th annual event, organized by EBD Group, the leading partnering firm for the life science industry, will be held at the CCH Congress Center Hamburg. Partnering opportunities began on Monday, October 1 for Europe's largest partnering conference servi...more ►

August 7, 2012BIO-Europe^® 2012 to be held in Hamburg, Germany"Gateway to the Nordic region" is ripe for dealmaking
EBD Group, the leading partnering firm for the life science industry, will hold the 18th annual BIO-Europe^® international partnering conference in Hamburg, Germany November 12–14, 2012 at the CCH Congress Center Hamburg. The 2011 event boasted 14,765 scheduled one-to-one meetings with 3,565 licensing opportunities posted from among 1,596 companies that attended. Partnering r...more ►

3 May 2013 Want success in China? Find an experienced Chinese partner “In China, unless you have deep resources, it is difficult to come and do everything yourself,” said Greg Scott of ChinaBio^®. “The market is fragmented, distribution is complex, and drug approval and pricing are complicated. It may take longer than in the West to bring a product to market, and business is conducted differently.” more ►

18 March 2013 Elegant dysfunction in the push-pull of partnering Everything has changed in partnering on both sides of the table except the necessary tension for negotiating a good deal. Yet if the relations between VCs and pharma executives are strained, they still can't get enough of each other. more ►

18 March 2013 Human data and teaching buyers won big deals in 2012 A mix of novel science and bold selling strategies won the big bio-bucks and stole headlines as top deals over the past year. A few of the winners shared their secrets in this panel session at BIO-Europe Spring^® 2013. more ►

18 March 2013 Stem cells: Do we need to wait 25 years for the Next Big Thing? With a Nobel Prize in 2012 and phenomenal potential for diagnostics and therapies, no one doubts that the next big thing will be stem cell derived products. In these (very) early days, this BIO-Europe Spring^® session presented current initiatives and challenges. more ►

18 March 2013 EU austerity puts pharma under “the tyranny of the urgent” Dramatic cost cutting in the five nations hardest hit by austerity measures is having "transmission effects" across the European Union with price cuts, reimbursement review and increasingly tender offers. more ►